SEC Form 4 · accession 0001127602-17-030076
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E Abernathy
Director
Period of report
Oct 17, 2017
Accepted (ET)
Oct 19, 2017 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 17, 2017 | A | 2,909 | $45.295 | A | 2,909 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted Stock Unit grant which vests 100% on July 27, 2018. Grant was made under 2005 Long Term Incentive Compensation Plan